Drug Shortage Report for TEVA-MYCOPHENOLATE
Report ID | 153171 |
Drug Identification Number | 02364883 |
Brand name | TEVA-MYCOPHENOLATE |
Common or Proper name | MYCOPHENOLATE 250MG CAPS |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | MYCOPHENOLATE MOFETIL |
Strength(s) | 250MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | UD 100 |
ATC code | L04AA |
ATC description | IMMUNOSUPPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-01-19 |
Estimated end date | 2023-10-10 |
Actual end date | 2023-10-05 |
Shortage status | Resolved |
Updated date | 2023-10-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v43 | 2023-10-06 | French | Compare |
v42 | 2023-10-06 | English | Compare |
v41 | 2023-10-04 | French | Compare |
v40 | 2023-10-04 | English | Compare |
v39 | 2023-08-08 | French | Compare |
v38 | 2023-08-08 | English | Compare |
v37 | 2023-07-20 | French | Compare |
v36 | 2023-07-20 | English | Compare |
v35 | 2023-07-20 | English | Compare |
v34 | 2023-07-04 | French | Compare |
v33 | 2023-07-04 | English | Compare |
v32 | 2023-06-09 | French | Compare |
v31 | 2023-06-09 | English | Compare |
v30 | 2023-04-27 | French | Compare |
v29 | 2023-04-27 | English | Compare |
v28 | 2023-02-09 | French | Compare |
v27 | 2023-02-09 | English | Compare |
v26 | 2023-01-12 | French | Compare |
v25 | 2023-01-12 | English | Compare |
v24 | 2023-01-09 | French | Compare |